We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Ligand Pharmaceuticals Incorporated
2 own
7 watching
Current Price
$59.92
$-1.57
(-2.55%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
1,272.71M
52-Week High
97.65000
52-Week Low
52.60761
Average Volume
0.08M
Dividend Yield
--
P/E Ratio
54.9356
Market Capitalization1,272.71M52-Week High97.6500052-Week Low52.60761Average Volume0.08MDividend Yield--P/E Ratio54.9356What does the Ligand Pharmaceuticals Incorporated do?
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing and acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Promacta, an oral medicine that increases the number of platelets in the blood; Kyprolis and Evomela, which are used to treat multiple myeloma; CorMatrix portfolio of vascular, cardiac, and pericardial tissue repair products; bazedoxifene, which is used for the treatment of postmenopausal osteoporosis; Carnexiv that is used as replacement therapy for oral carbamazepine formulations; Nexterone, a Captisol-enabled formulation of amiodarone; Noxafil-IV, a Captisol-enabled formulation of posaconazole for IV use; Exemptia for autoimmune diseases; and Vivitra for breast cancer. The company's partners programs, which are in clinical development used for the treatment of seizure, coma, cancer, diabetes, cardiovascular disease, muscle wasting, liver disease, kidney disease, and others. Its internal development program comprise products for the treatment of Type 2 diabetes mellitus, oncology, allergy, anti-coagulant, depression, sun damage, blood disorders, and diabetes. The company is also involved in the sale of Captisol materials. Ligand Pharmaceuticals Incorporated has alliances, licenses, and other business relationships with various pharmaceutical companies, including Novartis AG; Amgen, Inc.; Merck & Co., Inc.; Pfizer Inc.; Celgene; Gilead Sciences; Janssen Biotech, Inc.; Baxter International, Inc.; and Eli Lilly and Company. The company was founded in 1987 and is headquartered in San Diego, California.
Read More
How much money does Ligand Pharmaceuticals Incorporated make?
News & Events about Ligand Pharmaceuticals Incorporated.
Globe Newswire
3 months ago
One poster examines baseline vaginal and vulvar symptoms in ESR1-mutated, ER+/HER2- metastatic breast cancerSecond poster shares survey results examining vaginal and sexual health in ER+/HER2- metastatic breast cancer patients COLUMBUS, Ohio, June 29, 2023 (GLOBE NEWSWIRE) -- Sermonix ...
Globe Newswire
3 months ago
Sermonix used the Tempus TIME Trial Network to enroll 45% of its ELAINE-2 patientsThe company is again partnering with Tempus to enroll patients in its Phase 3 ELAINE-3 study COLUMBUS, Ohio, June 26, 2023 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company ...
Globe Newswire
6 months ago
VIENNA, Austria, March 15, 2023 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic breast and gynecological cancers harboring ESR1 mutations, today presented an e-poster at the St. Gallen ...
Globe Newswire
6 months ago
Prospective screening of subjects for ESR1 mutations will use the Guardant360 CDx blood test for companion diagnostic developmentPhase 3 study is supported by previously presented ELAINE-1 and ELAINE-2 Phase 2 study resultsSermonix anticipates dosing the first patient in first half of 2023 COLUMBUS...
Globe Newswire
6 months ago
ST. LOUIS, March 06, 2023 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic breast and gynecological cancers harboring ESR1 mutations, today announced that its lead drug candidate, ...
Frequently Asked Questions
Frequently Asked Questions
What is Ligand Pharmaceuticals Incorporated share price today?
Can Indians buy Ligand Pharmaceuticals Incorporated shares?
How can I buy Ligand Pharmaceuticals Incorporated shares from India?
Can Fractional shares of Ligand Pharmaceuticals Incorporated be purchased?
What are the documents required to start investing in Ligand Pharmaceuticals Incorporated stocks?
What is today’s traded volume of Ligand Pharmaceuticals Incorporated?
What is today’s market capitalisation of Ligand Pharmaceuticals Incorporated?
What is the 52-Week High and Low Range of Ligand Pharmaceuticals Incorporated?
What percentage is Ligand Pharmaceuticals Incorporated down from its 52-Week High?
What percentage is Ligand Pharmaceuticals Incorporated up from its 52-Week Low?
Current Price
$59.92
$-1.57
(-2.55%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.